Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

[Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma].

  • Authors : Hou Y; Sino-US Center for Lymphoma and Leukemia, Tianjin 300060, China.; Wang HQ

Subjects: Antibodies, Monoclonal, Murine-Derived/Antibodies, Monoclonal, Murine-Derived/Antibodies, Monoclonal, Murine-Derived/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, B-Cell/Lymphoma, B-Cell/Lymphoma, B-Cell/*drug therapy

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2012 Apr; Vol. 34 (4), pp. 306-10.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[A prospective multicenter study of rituximab combined with high-dose chemotherapy and autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma].

  • Authors : Shi YK; Department of Medical Oncology, Cancer Hospital (Institute), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. ; Yang S

Subjects: Peripheral Blood Stem Cell Transplantation*; Antibodies, Monoclonal, Murine-Derived/Antibodies, Monoclonal, Murine-Derived/Antibodies, Monoclonal, Murine-Derived/*therapeutic use ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use DICE protocol; EPOCH protocol; VAP-cyclo protocol

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2009 Aug; Vol. 31 (8), pp. 592-6.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Clinical analysis of 140 cases of mantle cell lymphoma].

  • Authors : Hu MW; Department of Hematology, Xinhua Hospital of Zhejiang Province, Hangzhou 310014, China.; Lou YJ

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, Mantle-Cell/Lymphoma, Mantle-Cell/Lymphoma, Mantle-Cell/*drug therapy; Antibodies, Monoclonal, Murine-Derived/Antibodies, Monoclonal, Murine-Derived/Antibodies, Monoclonal, Murine-Derived/administration & dosage

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2018 May 23; Vol. 40 (5), pp. 390-395.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Efficacy and safety of rituximab combined with CHOP or combined with dose fractionated CHOP in the treatment of primary gastric diffuse large B cell lymphoma].

  • Authors : Ji D; Department of Medical Oncology, Cancer Hospital; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/*drug therapy; Adult Familial primary gastric lymphoma

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2014 Dec; Vol. 36 (12), pp. 939-43.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Comparative analysis of liver function in HBsAg-/HBcAb+ patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP regimens].

  • Authors : Huang YH; Department of Medical Oncology, Chinese Academy Medical Sciences, Beijing, China.; He XH

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/*drug therapy; Alanine Transaminase/Alanine Transaminase/Alanine Transaminase/blood VAP-cyclo protocol

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2012 May; Vol. 34 (5), pp. 385-9.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Comparison of the efficacy of CCCG-97 and BFM-90 protocols in the treatment for children with mature B-cell non-Hodgkin's lymphoma].

  • Authors : Meng JH; Hematology/Oncology Department of Children's Hospital of Fudan University, Shanghai 201102, China.; Gao YJ

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Burkitt Lymphoma/Burkitt Lymphoma/Burkitt Lymphoma/*drug therapy ; Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/*drug therapy

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2012 Mar; Vol. 34 (3), pp. 222-7.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Clinical analysis of primary gastric diffuse large B-cell lymphoma].

  • Authors : Zhang J; Department of Medical Oncology, Cancer Hospital, Fudan University, Shanghai, China.; Wang MY

Subjects: Radiotherapy, High-Energy*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/*therapy CHOP protocol

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2010 Aug; Vol. 32 (8), pp. 614-8.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Relationship between clinopathological features and outcome of rituximab treatment for diffuse large B-cell lymphoma].

  • Authors : Zhang HY; Department of Medical Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510060, China.; Guan ZZ

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/*drug therapy CHOP protocol

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2008 May; Vol. 30 (5), pp. 381-4.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

×
  • 1-8 of  8 results for ""Antibodies, Monoclonal, Murine-Derived""